849532-31-6 Usage
Description
4-Bromo-N,N,3-trimethylbenzenesulphonamide is a chemical compound with the molecular formula C10H14BrNO2S. It is a sulphonamide derivative featuring a bromine atom and three methyl groups attached to a benzene ring. 4-Bromo-N,N,3-trimethylbenzenesulphonamide is known for its potential utility in various chemical reactions and processes due to its unique structural features.
Uses
Used in Organic Synthesis:
4-Bromo-N,N,3-trimethylbenzenesulphonamide is used as a reagent or intermediate in organic synthesis for the production of pharmaceuticals and agrochemicals. Its presence of a bromine atom and the N,N,3-trimethyl substituents on the benzene ring make it a versatile building block for creating a variety of complex organic molecules.
Used in Materials Science:
In the field of materials science, 4-Bromo-N,N,3-trimethylbenzenesulphonamide may be utilized for the development of new materials with specific properties. Its unique chemical structure can contribute to the creation of materials with tailored characteristics for various applications.
Used in Organic Chemistry Research:
4-Bromo-N,N,3-trimethylbenzenesulphonamide can also be employed in organic chemistry research to explore novel reaction pathways, mechanisms, and the synthesis of new organic compounds. Its structural attributes provide a foundation for investigating a wide range of chemical transformations and interactions.
Check Digit Verification of cas no
The CAS Registry Mumber 849532-31-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,9,5,3 and 2 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 849532-31:
(8*8)+(7*4)+(6*9)+(5*5)+(4*3)+(3*2)+(2*3)+(1*1)=196
196 % 10 = 6
So 849532-31-6 is a valid CAS Registry Number.
InChI:InChI=1/C9H12BrNO2S/c1-7-6-8(4-5-9(7)10)14(12,13)11(2)3/h4-6H,1-3H3
849532-31-6Relevant articles and documents
NAPHTHYLACETIC ACIDS
-
Page/Page column 84, (2010/06/15)
The invention is concerned with the compounds of formula (I) and pharmaceutically acceptable salts and esters thereof, wherein X, Q, and R1-R6 are defined in the detailed description and claims. In addition, the present invention relates to methods of manufacturing and using the compounds of formula (I) as well as pharmaceutical compositions containing such compounds. The compounds of formula (I) are antagonists or partial agonists at the CRTH2 receptor and may be useful in treating diseases and disorders associated with that receptor such as asthma.
